| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,539 |
30,417 |
$5.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
34,851 |
30,626 |
$4.88M |
| 71045 |
Radiologic examination, chest; single view |
9,163 |
7,785 |
$1.31M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,760 |
4,787 |
$830K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,727 |
9,193 |
$799K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,095 |
911 |
$773K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,715 |
9,427 |
$733K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
454 |
397 |
$563K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,968 |
5,330 |
$461K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,673 |
2,391 |
$436K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,978 |
928 |
$406K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,894 |
2,832 |
$392K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,101 |
5,895 |
$328K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,671 |
6,671 |
$321K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,712 |
5,840 |
$296K |
| 80053 |
Comprehensive metabolic panel |
39,342 |
30,992 |
$279K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
46,598 |
35,629 |
$243K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,407 |
8,511 |
$230K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
130 |
118 |
$224K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,908 |
1,814 |
$192K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
111 |
90 |
$180K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
432 |
355 |
$178K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,480 |
1,315 |
$171K |
| 71046 |
Radiologic examination, chest; 2 views |
2,120 |
1,823 |
$170K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
45 |
44 |
$123K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,778 |
1,634 |
$123K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,067 |
969 |
$111K |
| 36415 |
Collection of venous blood by venipuncture |
31,197 |
24,500 |
$96K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
54 |
51 |
$74K |
| 64493 |
|
117 |
101 |
$51K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,769 |
1,593 |
$46K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,449 |
572 |
$45K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,208 |
813 |
$38K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
189 |
174 |
$35K |
| 84484 |
|
4,143 |
2,441 |
$34K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
552 |
391 |
$30K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
251 |
204 |
$30K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
503 |
155 |
$29K |
| 70450 |
Computed tomography, head or brain; without contrast material |
271 |
225 |
$29K |
| 97161 |
|
383 |
308 |
$28K |
| 81001 |
|
10,700 |
8,795 |
$23K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,061 |
366 |
$21K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
901 |
324 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
100 |
94 |
$19K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
686 |
573 |
$18K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
780 |
738 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
101 |
96 |
$17K |
| 81025 |
|
3,073 |
2,530 |
$16K |
| 64483 |
|
17 |
15 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,430 |
1,403 |
$15K |
| 83690 |
|
3,865 |
3,114 |
$14K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,266 |
2,499 |
$14K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
280 |
256 |
$11K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
493 |
464 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
259 |
217 |
$10K |
| 99221 |
|
32 |
12 |
$9K |
| 96523 |
|
123 |
106 |
$9K |
| 80055 |
|
293 |
277 |
$9K |
| 83735 |
|
1,764 |
1,505 |
$9K |
| 87634 |
|
145 |
136 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
65 |
59 |
$8K |
| 97014 |
|
99 |
27 |
$7K |
| 64494 |
|
82 |
75 |
$5K |
| 87430 |
|
1,015 |
886 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
27 |
25 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,240 |
844 |
$5K |
| 76801 |
|
27 |
27 |
$5K |
| 27096 |
|
15 |
15 |
$5K |
| 80050 |
General health panel |
28 |
26 |
$4K |
| 82728 |
|
510 |
443 |
$4K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
551 |
194 |
$4K |
| 81003 |
|
2,305 |
1,974 |
$4K |
| 83615 |
|
605 |
488 |
$4K |
| 80061 |
Lipid panel |
472 |
398 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
525 |
447 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
47 |
44 |
$3K |
| 36591 |
|
80 |
41 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
197 |
168 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
83 |
65 |
$3K |
| 76830 |
Ultrasound, transvaginal |
14 |
14 |
$2K |
| 83540 |
|
501 |
440 |
$2K |
| 93017 |
|
26 |
13 |
$2K |
| 83550 |
|
325 |
280 |
$2K |
| 84703 |
|
330 |
280 |
$2K |
| 87081 |
|
738 |
639 |
$2K |
| 96367 |
|
48 |
25 |
$2K |
| 82607 |
|
145 |
134 |
$1K |
| 82746 |
|
128 |
117 |
$1K |
| 84439 |
|
210 |
183 |
$1K |
| 83655 |
|
81 |
76 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
169 |
131 |
$974.36 |
| 82077 |
|
70 |
53 |
$884.22 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
174 |
152 |
$878.19 |
| 85027 |
|
222 |
187 |
$861.58 |
| 94060 |
|
13 |
12 |
$798.96 |
| 72110 |
|
13 |
13 |
$734.26 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
81 |
69 |
$710.63 |
| 84436 |
|
115 |
104 |
$525.39 |
| 82950 |
|
130 |
122 |
$519.66 |
| 84702 |
|
49 |
36 |
$463.27 |
| 85651 |
|
106 |
96 |
$306.71 |
| 85610 |
|
267 |
162 |
$273.18 |
| 84146 |
|
28 |
16 |
$264.72 |
| 82747 |
|
14 |
13 |
$195.16 |
| 82105 |
|
12 |
12 |
$187.82 |
| 85379 |
|
29 |
26 |
$181.51 |
| 86803 |
|
13 |
13 |
$179.92 |
| 85730 |
|
32 |
29 |
$106.54 |
| 84550 |
|
60 |
45 |
$100.87 |
| 87420 |
|
14 |
12 |
$73.71 |
| 80076 |
|
13 |
12 |
$70.23 |
| 82248 |
|
16 |
12 |
$43.13 |
| 85007 |
|
21 |
15 |
$39.81 |
| 84100 |
|
13 |
12 |
$34.02 |
| 94729 |
|
13 |
12 |
$13.36 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
356 |
268 |
$2.40 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,049 |
4,037 |
$1.01 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,926 |
3,173 |
$0.70 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
569 |
487 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,427 |
1,884 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
349 |
288 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
551 |
442 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
159 |
140 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
341 |
126 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
98 |
54 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
94 |
61 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
30 |
24 |
$0.00 |
| 77002 |
|
14 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,721 |
2,224 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,332 |
1,109 |
$0.00 |
| 88342 |
|
20 |
15 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
54 |
43 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
136 |
112 |
$0.00 |
| 88304 |
|
33 |
28 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
115 |
105 |
$0.00 |
| 90744 |
|
13 |
13 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
42 |
27 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
13 |
13 |
$0.00 |